![Andrey Mladentsev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrey Mladentsev
Nessuna posizione attualmente
Profilo
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Precedenti posizioni note di Andrey Mladentsev
| Società | Posizione | Fine |
|---|---|---|
| STADA ARZNEIMITTEL | Investitore di Private Equity | 01/03/2007 |
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Consulente / Consigliere | - |
Formazione di Andrey Mladentsev
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
IEDC Bled School of Management
 IEDC Bled School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Finance |
